ESR1 and breast carcinoma: However, several studies suggest that low concentrations (1 - 20 μM) of RES exert an ER-mediated mitogenic effect in ER-positive breast cancer cells, but that high concentrations (60-100 μM) of RES exhibit ER-independent anti-proliferative activity [10, 11].